Citation Impact
Citing Papers
Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE /NF ‐KB /JNK signaling pathway in aging mouse model
2014 Standout
The endocannabinoid nervous system
2001
The endocannabinoid system as a target for therapeutic drugs
2000
Endocannabinoids and exercise
2004
Different responses to dexamethasone and prednisolone in the same depressed patients
2006
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Nonuniform Cardiac Denervation Observed by 11C-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys
2012
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages
2010
Adverse Health Effects of Marijuana Use
2014 Standout
Descending control of pain
2002 Standout
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Glutamate uptake
2001 Standout
Fine‐motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome
2005
A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene
1999
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Noninvasive assessment of the relative roles of cerebral antioxidant enzymes by quantitation of pentose phosphate pathway activity
1996
Parkinson's disease: clinical features and diagnosis
2008 Standout
Orthostatic hypotension as an early finding in Parkinson’s disease
2006
Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease
2014
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
2004
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
2005
In vivo imaging of synaptic function in the central nervous system
2009
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
1987 Standout
The endocannabinoid system and its therapeutic exploitation
2004
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Cannabinoids and glaucoma
2004
Gut microbiome and health: mechanistic insights
2022 Standout
Molecular Imaging Studies in Parkinson Disease
2009
Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatments
2012
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
2009
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Regulation of cancer cell metabolism
2011 Standout
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Metabolic flux determination in C6 glioma cells using carbon‐13 distribution upon [1‐13C]glucose incubation
1993
Metabolic fluxes in riboflavin-producing Bacillus subtilis
1997 StandoutNobel
Pharmacokinetics and Pharmacodynamics of Cannabinoids
2003
Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose
2007 Standout
Neurological and neuropsychiatric syndromes associated with liver disease
2005
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
1998
The endogenous cannabinoid system and the basal ganglia
2002
Partial pressure of ammonia versus ammonia in hepatic encephalopathy
2000
Ammonia downregulates GLAST mRNA glutamate transporter in rat astrocyte cultures
1999
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
A proteomic approach in the study of an animal model of Parkinson's disease
2005
Neuroprotective Strategies in Parkinson???s Disease
2003
The HPA axis in major depression: classical theories and new developments
2008 Standout
Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
2011
The molecular logic of endocannabinoid signalling
2003 Standout
Functional imaging with positron emission tomography in multiple system atrophy
2005
Non-motor features of Parkinson disease
2017 Standout
Cannabinoids in medicine: A review of their therapeutic potential
2006
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
2008 Standout
Cannabinoid receptors and their ligands
2002
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
2007 Standout
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson’s Disease
2003
Synergy and other interactions in phytomedicines
2001 Standout
Imaging biomarkers in Parkinson's disease
2011
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
2007 Standout
The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers
2005
Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats
2016 Standout
Cannabinoids in Clinical Practice
2000
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
2000
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
2002 Standout
Human Cannabinoid Pharmacokinetics
2007 Standout
Human Studies of Cannabinoids and Medicinal Cannabis
2005
Cannabinoids and the expanded endocannabinoid system in neurological disorders
2019
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
2001
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Age-Dependent Changes in Central Dopaminergic and Other Monoaminergic Systems
1978 StandoutNobel
Aspects of Carbohydrate Metabolism in Developing Brain
1977
Inhibitory actions of desacetylation products of phenacetin and paracetamol on prostaglandin synthetases in neuronal and glial cell lines and rat renal medulla
1982
Fundamentals of cancer metabolism
2016 Standout
Trials of pharmacological interventions for Tourette syndrome: a systematic review.
2013
Status spongiosus of nervous tissue
1971
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA
1976
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.
1998
Vision assessment using the NIH Toolbox
2013 Standout
Cannabinoids in health and disease
2007
Biology and Structure of Scrapie Prions
1986 StandoutNobel
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
2000
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Cannabinoids for Medical Use
2015 Standout
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
The Metabolic Substrates of Bradykinesia and Tremor in Uncomplicated Parkinson's Disease
2002
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells
2013
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Cannabinoids for Tourette's Syndrome
2009
PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
2006
Works of H. Kolbe being referenced
The Basal Ganglia and Portal-Systemic Encephalopathy
1998
Gilles de la Tourette-Syndrom
1997
Dopamine transporter binding in Gilles de la Tourette syndrome
2000
Cannabis in Movement Disorders
1999
Cannabinoids: possible role in patho‐physiology and therapy of Gilles de la Tourette syndrome
1998
Influence of Treatment of Tourette Syndrome with Δ9-Tetrahydrocannabinol (Δ9-THC) on Neuropsychological Performance
2001
Delta 9-Tetrahydrocannabinol (THC) is Effective in the Treatment of Tics in Tourette Syndrome
2003
[ N -methyl 11 C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy
2003
Dopamine D2 receptor imaging inGilles de la Tourette syndrome
2000
Disturbed Monitoring and Response Inhibition in patients with Gilles De La Tourette Syndrome and Co‐Morbid Obsessive Compulsive Disorder
2002
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET
2001
Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Δ9-THC): No Influence on Neuropsychological Performance
2003
Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial
2002
Treatment of Tourette’s Syndrome With Delta-9-Tetrahydrocannabinol
1999
Glucose metabolism in C-1300 neuroblastoma cells after inhibition of hexose monophosphate pathway
1977
Der Kohlenhydratstoffwechsel des Gehirns nach Blockade des Pentose-Phosphat-Weges durch 6-Aminonicotinsäureamid
1970
Brain disorders induced by pharmacological blockade of the pentose phosphate pathway
1969
Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells
1976
[123I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson’s disease and multiple system atrophy
2003